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1. Introduction 
Leucine and methionine-enkephalin [l] and 
cy-, fl- and y-endorphin [2-61 are peptides with opiate- 
like activity that have been isolated from brain. With 
the exception of leucine-enkephalin they appear to 
be fragments of fl-lipotropic hormone @-LPH). Like 
morphine they bind to opiate-receptors [3,5,7,8] , 
inhibit the electrically stimulated contraction of 
guinea-pig ileum [ 1,3,9] and cause analgesia [6,11] 
and tolerance [12-141 . In addition, in rats y-endor- 
phin was demonstrated to enhance irritability [ 151 
and /3-endorphin to cause long-lasting catatonia [ 15, 
161. All these effects of the opioid peptides can be 
prevented by the opiate-antagonist naloxone [l-3, 
9-l 1,15,16]. This confirms the notion that the 
opioid peptides act by binding to opiate receptors. 
Opiates [ 17,181, the enkephalins [ 19,201 and some 
of their analogues [21,22] have also been demonstrated 
to act on the opiate-receptors of neuroblastoma X 
X glioma hybrid cells in culture. These cells exhibit 
many properties characteristic of neurons [23-251. 
In the presence of prostaglandin Er (PGEr) the 
concentration of adenosine 3’5’-cyclic monophos- 
phate (cyclic AMP) is increased in the hybrid cells 
[26] . The rise in the level of cyclic AMP is much 
more strongly suppressed by the two equipotent 
enkephalins than by opiates [ 191. Here we communi- 
cate that on the hybrid cells (Y-, f3- and y-endorphins 
act qualitatively similar to methionine-enkephalin, 
although they are less potent (potency: methionine- 
enkephalin > (Y- and f3-endorphin > y-endorphin). A 
preliminary report of some of the data has appeared 
u71. 
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2. Materials and methods 
Methionine-enkephalin @-LPH-[61-651) and 
leucine-enkephalin were synthesized by Moroder 
and Wiinsch [ 19,281, a-endorphin @-LPH- [6 l-761 ) 
[2] , fl-endorphin @-LPH- [6 l-9 1 ] ) [3 ] and 
y-endorphin @LPH-[61-771) [3] were generous 
gifts from Drs R. Guillemin and N. Ling. Naloxone . HCl 
and PGEr were gifts from Hoffman-LaRoche, Grenzach, 
Germany, and Dr J. Pike, Upjohn Co., Kalamazoo, 
Michigan, respectively. 2.4 X 10’ viable (exclusion of 
nigrosin) neuroblastoma X glioma hybrid cells 
108CC 15 were seeded onto plastic dishes (85 mm in 
diameter, containing 20 ml of growth medium) and 
cultured as described [29] . Four days later the 
medium was removed, the cells were washed once 
with 5 ml of incubation medium (37°C) and, unless 
stated otherwise, were incubated (37°C 10 min) with 
5 ml of this medium containing PGEr (0.3 PM) and 
the peptides. Thereafter, the intracellular concentra- 
tion of cyclic AMP was determined [29]. 
3. Results 
Like methionine-enkephalin, also the three endor- 
phins inhibit the action of PGE, (tig.1). The endorphins 
are, however, less potent than the enkephalins. The 
concentrations at which the effect of PGEr is inhibit- 
ed by 50% (I&e) increases from 1 nM for methionine- 
enkephalin to 5,lO and 40 nM for P-, (Y-, and 
y-endorphin, respectively. From one experiment to 
another these values may vary within the range of 
approximately half an order of magnitude. 
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Fig.1. Methionine-enkephalin (curve I), p-endorphin (curve II), 
o-endorphin (curve III) and y-endorphin (curve IV) inhibit 
the increase in the level of cyclic AMP caused by PGE,. Mean 
values + s.d. from 3 parallel incubations. 1.6 X lo6 viable 
hybrid cells, viability 91%, passage number 13. 
The effects of the endorphins can be blocked by 
the opiate antagonist naloxone. In table 1 this is 
exemplified for /3-endorphin. As positive controls, 
similar data for leucine-enkephalin are included. 
Previous experiments had demonstrated that enke- 
phalins are slowly inactivated, probably by prote- 
olysis, when exposed to the hybrid cell culture [ 19,20, 
301. The possibility had to be considered that also 
the endorphins are degraded by proteolysis. This 
could imply that the endorphins are inactive peptides 
not affecting the formation of cyclic AMP in the 
hybrid cells. From the endorphins active peptides 
such as methionine-enkephalin could be generated 
during the 10 min incubation. From this hypothesis 
would follow that the endorphin would, at best, only 
slightly inhibit the effect of PGE, during the early 
phase of the incubation. The inhibition should increase 
with the time of the incubation. However, this is not 
the case. Like leucine-enkephaline, /3-endorphin 
inhibits the action of PCEr already at the shortest 
time of incubation that was chosen (0.5 min; fig. 2). 
4. Discussion 
The experiments demonstrate that Q-, /3- and 
y-endorphin act on neuroblastoma X glioma hybrid 
cells in a way comparable to that of the enkephalins 
and opiates. They inhibit the increase in the level of 
cyclic AMP evoked by PGEr . Naloxone blocks the 
effects of the endorphins. This indicates that, in order 
to cause their effects, these peptides must bind to 
the opiate receptors on the hybrid cells. These results 
Table 1 
The opiate antagonist naloxone inhibits the action of p-endorphin. Mean 
values + s.d. from 3 parallel incubations. 2.2 X lo6 viable cells per 
plate, viability 92%, passage number 21 
Addition (PM) Cyclic AMP (pmol/mg protein) 
none 
PGE, (0.3) 
PGE, + naloxone (10) 
PGE, + leucine-enkephalin (0.1) 
PGE, + leucine-enkephalin + naloxone 
PGE, + @-endorphin (0.01) 
PGE, + P-endorphin (0.1) 
PGE, + p-endorphin (0.01) + naloxone 
PGE, + p-endorphin (0.1) + naloxone 
19t 2 
815 * 40 
860 f 45 
200 + 10 
680* 60 
450+ 45 
280r 90 
880 + 110 
720 f 90 
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Fig.2. p-Endorphin (0.1 PM; curve I) and leucine-enkephalin 
(0.1 PM; curve II) inhibit the increase in the intracellular 
level of cyclic AMP evoked by PGE, (0.3 PM; curve III) in 
hybrid cells. In order to provide a better constancy of the 
pH value during the short-term incubations, the incubations 
were carried out in Dulbecco’s Modified Eagle’s Medium 
(pH 7.4), in which NaHCO, had been replaced by 25 mM 
N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid 
(HEPES) and 19 mM NaCl. The alteration of the medium has no 
influence on the results. Note that for better display of the 
data at short times, the time values (abscissa) are plotted 
logarithmically. Mean values r s.d. from 3 parallel incubations. 
1.4 X lo6 viable cells, viability 94%, passage number 15. 
agree with the observations that the actions of the 
endorphins on small intestine [l] and brain [ 11 ,17, 
181 are also antagonized by naloxone. 
From the fact that P-endorphin inhibits already at 
short periods of incubation it is concluded that it acts 
directly on the cells without prior degradation to 
shorter peptides such as methionine-enkephalin. Prob- 
ably this is also true for the other endorphins. In 
their influence on the hybrid cells the endorphins are 
approximately one order of magnitude less potent 
than the enkephalins. On the other hand it is compa- 
rable to that of two other fragments of P-LPH, 
/_CLPH-[61-691 and@LPH-[61-751 [21]. Thus, it 
appears that elongation at the carboxyl end of the 
peptide chain of enkephalin yields peptides of reduced 
potency. However, the potency does not decrease 
inversely to the length of the peptide chain. This is 
exemplified best by the fact that the potency of 
P-endorphin is higher than that of the shorter peptide 
y-endorphin. 
The neuroblastoma X glioma hybrid cells can be 
considered as a model system for neurons with which 
they have in common characteristic neuronal markers 
[24,25]. Thus, it is hypothesized that the mechanisms 
of action of opioid peptides observed with the hybrid 
cells will be found in neurons carrying opiate receptors. 
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